-
EP3866831
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3866831
| EP3866831 - IDENTIFICATION AND TARGETING OF PATHOGENIC EXTRACELLULAR MATRIX FOR DIAGNOSIS AND TREATMENT OF CANCER AND OTHER DISEASES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.07.2021 Database last updated on 22.01.2025 | |
| Former | The international publication has been made Status updated on 24.04.2020 | Most recent event Tooltip | 13.09.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Board of Regents, The University of Texas System 210 West 7th St. Austin, TX 78701 / US | [N/P] |
| Former [2021/34] | For all designated states Board of Regents, The University of Texas System 210 West 7th St. Austin TX 78701 / US | Inventor(s) | 01 /
KALLURI, Raghu c/o The University Of Texas Md Anderson Cancer Center 1515 Holcombe Blvd. Houston, TX 77030 / US | 02 /
LEBLEU, Valerie c/o The University Of Texas Md Anderson Cancer Center 1515 Holcombe Blvd. Houston, TX 77030 / US | 03 /
CHEN, Yang c/o The University Of Texas Md Anderson Cancer Center 1515 Holcombe Blvd. Houston, TX 77030 / US | [2021/34] | Representative(s) | SONN Patentanwälte GmbH & Co KG Riemergasse 14 1010 Wien / AT | [N/P] |
| Former [2021/34] | SONN Patentanwälte OG Riemergasse 14 1010 Wien / AT | Application number, filing date | 19874574.7 | 16.10.2019 | [2021/34] | WO2019US56576 | Priority number, date | US201862746286P | 16.10.2018 Original published format: US 201862746286 P | [2021/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020081714 | Date: | 23.04.2020 | Language: | EN | [2020/17] | Type: | A1 Application with search report | No.: | EP3866831 | Date: | 25.08.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.04.2020 takes the place of the publication of the European patent application. | [2021/34] | Search report(s) | International search report - published on: | US | 23.04.2020 | (Supplementary) European search report - dispatched on: | EP | 27.07.2022 | Classification | IPC: | C07K16/18, C07K16/30, A61K38/17, A61K39/00, C07K14/705 | [2022/34] | CPC: |
A61K39/0011 (EP,US);
C07K16/18 (EP,KR,US);
A61K31/706 (KR);
A61K35/17 (EP,US);
A61K40/11 (KR);
A61K40/42 (KR);
A61K45/06 (US);
A61P35/00 (KR,US);
C07K14/4705 (EP);
C07K14/7051 (KR);
C07K14/70517 (KR);
C07K14/70521 (KR);
C07K14/78 (EP);
C07K16/2809 (US);
C12N15/85 (KR);
C12N9/0069 (EP);
C12N9/22 (EP);
G01N33/57438 (EP,US);
G01N33/6887 (EP);
A01K2217/052 (EP);
A01K2217/075 (EP);
A01K2217/15 (EP);
A01K2217/206 (EP);
A01K2227/105 (EP);
A01K2267/0331 (EP);
A61K2039/505 (EP,KR);
A61K2039/5158 (EP,US);
A61K2039/852 (EP,KR);
A61K2121/00 (KR);
A61K2300/00 (KR);
C07K2317/24 (KR);
C07K2317/31 (KR,US);
C07K2317/33 (US);
C07K2317/622 (KR);
C07K2317/92 (KR);
C07K2319/00 (EP);
C07K2319/02 (KR);
C07K2319/03 (KR,US);
C07K2319/60 (EP);
|
| Former IPC [2021/34] | A61K38/17, A61K39/00, C07K14/705 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/34] | Title | German: | IDENTIFIZIERUNG UND TARGETING DER PATHOGENEN EXTRAZELLULÄREN MATRIX ZUR DIAGNOSE UND BEHANDLUNG VON KREBS UND ANDEREN KRANKHEITEN | [2021/34] | English: | IDENTIFICATION AND TARGETING OF PATHOGENIC EXTRACELLULAR MATRIX FOR DIAGNOSIS AND TREATMENT OF CANCER AND OTHER DISEASES | [2021/34] | French: | IDENTIFICATION ET CIBLAGE DE MATRICE EXTRACELLULAIRE PATHOGÈNE POUR LE DIAGNOSTIC ET LE TRAITEMENT DU CANCER ET D'AUTRES MALADIES | [2021/34] | Entry into regional phase | 12.05.2021 | National basic fee paid | 12.05.2021 | Search fee paid | 12.05.2021 | Designation fee(s) paid | 12.05.2021 | Examination fee paid | Examination procedure | 12.05.2021 | Examination requested [2021/34] | 16.02.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 21.10.2021 | Renewal fee patent year 03 | 28.09.2022 | Renewal fee patent year 04 | 29.09.2023 | Renewal fee patent year 05 | 12.09.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]EP0738735 (ORION YHTYMAE OY [FI]); | [XI]WO03046204 (CELL MATRIX INC [US], et al); | [T]WO2020257296 (UNIV TEXAS [US]); | International search | [Y]US2005265993 (MACH BERNARD [CH], et al); | [Y]US2010303726 (WATKINS JEFFRY D [US], et al); | [Y]US2013316921 (COHEN HARVEY J [US], et al); | [Y]WO2017096327 (JUNO THERAPEUTICS INC [US]); | [Y]WO2017139694 (NANTOMICS LLC [US], et al); |